Young Kwon - Aug 23, 2024 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Young Kwon, by Adam S. Grossman as Attorney-in-fact
Stock symbol
ADMA
Transactions as of
Aug 23, 2024
Transactions value $
-$1,095,600
Form type
4
Date filed
8/27/2024, 09:00 PM
Previous filing
Feb 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Sale -$1.1M -60K -19.9% $18.26 241K Aug 23, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $18.25 to $18.27. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2 Includes, as of the transaction date, (i) 12,020 restricted stock units ("RSUs") granted on February 26, 2024, which will vest in full on February 26, 2025, subject to the Reporting Person's continued service as of the applicable vesting date; and (ii) 229,421 shares of common stock owned by the Reporting Person.

Remarks:

Exhibit 24 - Power of Attorney